Compositions and methods of functionally enhanced in vitro cell culture system

Patent metadata

Field	Value
Publication number	US-9243221-B2
Application number	US-200913131041-A
Country	US
Kind code	B2
Filing date	Nov 24, 2009
Priority date	Nov 26, 2008
Publication date	Jan 26, 2016
Grant date	Jan 26, 2016

Abstract

Compositions and methods described herein provide a cell culture system in which cells are in high metabolic states from the onset of the culture. Combinations of various cell culture components disclosed and employed herein allow cells to be in high metabolic states useful for drug testing immediately after the start of cell culture.

First claim

What is claimed is:

1. A cell culture system, comprising:
a) a cell culture compartment comprising a cell culture substrate and a cell culture medium comprising no more than about 10% serum;
b) a coculture of metabolically active primary hepatocytes and at least one other cell type, said coculture seeded onto the culture substrate and cultured in the culture medium; and
c) a gaseous composition in contact with the culture medium and comprising at least about 90% oxygen.

2. The cell culture system of claim 1 , wherein the culture medium comprises no more than about 5% serum.

3. The cell culture system of claim 1 , wherein the culture medium is serum free.

4. The cell culture system of claim 1 , wherein the at least one other cell type is a stromal cell type.

5. The cell culture system of claim 1 , wherein the at least one other cell type is a non-parenchymal cell type.

6. The cell culture system of claim 1 , wherein the ratio of the number of metabolically active primary hepatocytes to the number of cells of the at least one other cell type in the coculture is from about 1:10 to about 10:1.

7. The cell culture system of claim 1 , wherein the ratio of the number of metabolically active primary hepatocytes to the number of cells of the at least one other cell type in the coculture is from about 1:5 to about 5:1.

8. The cell culture system of claim 1 , wherein the gaseous composition in contact with the culture medium comprises at least about 95% oxygen.

9. The cell culture system of claim 1 , wherein the gaseous composition in contact with the culture medium comprises at least about 100% oxygen.

10. The cell culture system of claim 1 , wherein the coculture of metabolically active primary hepatocytes and the at least one other cell type are seeded into the culture compartment and cultured in the culture medium in contact with the gaseous composition for about one day.

11. The cell culture system of claim 10 , wherein following culturing in the culture medium in contact with the gaseous composition for about one day the level of albumin secretion by hepatocytes in the coculture is at least about 4-fold higher than the level of albumin secretion by hepatocytes in a control coculture comprising a gaseous composition in contact with the culture medium and comprising an atmospheric level of oxygen.

12. The cell culture system of claim 10 , wherein the level of albumin secretion by hepatocytes in the coculture is at least about 80 μg/1×10 6 cells /24 hrs.

13. The cell culture system of claim 10 , wherein the level of transcription of phase I and phase II enzymes in hepatocytes in the coculture is comparable to the level of transcription of phase I and phase II enzymes in freshly isolated hepatocytes.

14. The cell culture system of claim 10 , wherein the CYP1A1/2 activity level of hepatocytes in the coculture is comparable to the CYP1A1/2 activity level in freshly isolated hepatocytes.

15. A cell culture system made by a method comprising:
a) seeding a coculture of metabolically active primary hepatocytes and at least one other cell type onto a culture substrate; and
b) culturing the seeded coculture in a culture medium comprising no more than about 10% serum;
wherein during the seeding and/or culturing the culture medium is in contact with a gaseous composition comprising at least about 90% oxygen.

16. The cell culture system of claim 15 , wherein the culturing is for from about one to about three days.

17. The cell culture system of claim 15 , wherein the culture medium comprising no more than about 5% serum.

18. The cell culture system of claim 15 , wherein the culture medium is serum free.

19. The cell culture system of claim 15 , wherein the gaseous composition comprises at least about 95% oxygen.

20. The cell culture system of claim 15 , wherein the gaseous composition comprises at least about 100% oxygen.

21. A cell culture system, comprising:
a) a cell culture compartment comprising a cell culture substrate and a cell culture medium comprising no more than about 10% serum;
b) a coculture of metabolically active primary hepatocytes and at least one other cell type, said coculture seeded onto the culture substrate and cultured in the culture medium, wherein during the seeding and/or the first one to three days of culturing the culture medium is in contact with a gaseous composition comprising at least about 90% oxygen; and
c) a gaseous composition in contact with the culture medium and comprising at least about 90% oxygen;
wherein the level of albumin secretion by hepatocytes in the coculture is at least about 4-fold higher than the level of albumin secretion by hepatocytes in a control coculture comprising a gaseous composition in contact with the culture medium and comprising an atmospheric level of oxygen.

22. The cell culture system of claim 21 , wherein the level of albumin secretion by hepatocytes in the coculture is at least about 80 μg/1×10 6 cells /24 hrs.

23. The cell culture system of claim 21 , wherein the level of transcription of phase I and phase II enzymes in hepatocytes in the coculture is comparable to the level of transcription of phase I and phase II enzymes in freshly isolated hepatocytes.

24. The cell culture system of claim 21 , wherein the CYP1A1/2 activity level of hepatocytes in the coculture is comparable to the CYP1A1/2 activity level in freshly isolated hepatocytes.

Assignees

• Yarmush Martin
• Freedman Robert
• Nahmias Yaakov
• Novik Eric
• Hurel Corp
• Gen Hospital Corp

Inventors

• Yarmush Martin
• Freedman Robert
• Nahmias Yaakov
• Novik Eric

Classifications

• C12M23/12 Primary

  Well or multiwell plates (C12M25/04 takes precedence) · CPC title

• C12M35/08 Primary

  Chemical, biochemical or biological means, e.g. plasma jet, co-culture · CPC title

• C12M25/14

  Scaffolds; Matrices (in general C12N5/0068) · CPC title

• C12M23/16

  Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title

• C12N5/0671 Primary

  Three-dimensional culture, tissue culture or organ culture; Encapsulated cells · CPC title